← Back to Clinical Trials
Recruiting NCT06588777

NCT06588777 Ultrasound Guided Modified Thoracoabdominal Nerve Block Through Perichondrial Approach (M-TAPA) Versus Quadratus Lumborum Block for Postoperative Analgesia in Laparoscopic Cholecystectomy

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06588777
Status Recruiting
Phase
Sponsor Ain Shams University
Condition Laparoscopic Cholecystectomy
Study Type INTERVENTIONAL
Enrollment 52 participants
Start Date 2024-09-01
Primary Completion 2025-12-30

Eligibility & Interventions

Sex All sexes
Min Age 21 Years
Max Age 71 Years
Study Type INTERVENTIONAL
Interventions
Modified thoracoabdominal nerve block through perichondrial approach (M-TAPA)Quadratus lumborum block

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 52 participants in total. It began in 2024-09-01 with a primary completion date of 2025-12-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This study aims to compare the efficacy of using Ultrasound guided modified thoracoabdominal nerve block through perichondrial approach (M-TAPA) versus quadratus lumborum block for postoperative analgesia in laparoscopic cholecystectomy under general anesthesia.

Eligibility Criteria

Inclusion Criteria: * Adult patients aging ≥ 21 years to ≤ 70 of both sexes. * Patients undergoing Laparoscopic cholecystectomy surgeries. * ASA physical status classes I - II. Exclusion Criteria: * Patient's refusal of procedure or participation in the study. * ASA classes III or above. * Coagulopathy and bleeding disorders. * Evidence of Local skin infections at site of injection. * Body mass index \>40kg/m2 * A history of relevant local anesthetic allergy.

Contact & Investigator

Central Contact

Ahmed Hassan, Master

✉ ahmedhassan199466@gmail.com

📞 01158195158

Frequently Asked Questions

Who can join the NCT06588777 clinical trial?

This trial is open to participants of all sexes, aged 21 Years or older, up to 71 Years, studying Laparoscopic Cholecystectomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06588777 currently recruiting?

Yes, NCT06588777 is actively recruiting participants. Contact the research team at ahmedhassan199466@gmail.com for enrollment information.

Where is the NCT06588777 trial being conducted?

This trial is being conducted at Cairo, Egypt.

Who is sponsoring the NCT06588777 clinical trial?

NCT06588777 is sponsored by Ain Shams University. The trial plans to enroll 52 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology